Skip to main content

Main menu

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Collections
    • Podcast
  • ALERTS
  • FOR AUTHORS
    • Information for Authors
    • Fees
    • Journal Clubs
    • eLetters
    • Submit
    • Special Collections
  • EDITORIAL BOARD
    • Editorial Board
    • ECR Advisory Board
    • Journal Staff
  • ABOUT
    • Overview
    • Advertise
    • For the Media
    • Rights and Permissions
    • Privacy Policy
    • Feedback
    • Accessibility
  • SUBSCRIBE

User menu

  • Log out
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Neuroscience
  • Log out
  • Log in
  • My Cart
Journal of Neuroscience

Advanced Search

Submit a Manuscript
  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Collections
    • Podcast
  • ALERTS
  • FOR AUTHORS
    • Information for Authors
    • Fees
    • Journal Clubs
    • eLetters
    • Submit
    • Special Collections
  • EDITORIAL BOARD
    • Editorial Board
    • ECR Advisory Board
    • Journal Staff
  • ABOUT
    • Overview
    • Advertise
    • For the Media
    • Rights and Permissions
    • Privacy Policy
    • Feedback
    • Accessibility
  • SUBSCRIBE
PreviousNext
Correction

Correction: Sepers et al., “Endocannabinoid-Specific Impairment in Synaptic Plasticity in Striatum of Huntington's Disease Mouse Model”

Journal of Neuroscience 15 August 2018, 38 (33) 7364; https://doi.org/10.1523/JNEUROSCI.1804-18.2018
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

In the article, “Endocannabinoid-Specific Impairment in Synaptic Plasticity in Striatum of Huntington's Disease Mouse Model” by Marja D. Sepers, Amy Smith-Dijak, Jeff LeDue, Karolina Kolodziejczyk, Ken Mackie, and Lynn A Raymond, which appeared on pages 544–554 of the January 17, 2018 issue, the authors have become aware of an error in Figure 7B, where the legend indicating treatment in YAC128 iSPN was inadvertently reversed. The revised figure correctly shows untreated YAC128 iSPN with blue circles and YAC128 iSPN treated with URB597 with gray circles. In addition, we have changed the legend to clarify that the same group of untreated YAC128 iSPN is presented in all panels for comparison with drug treatments. The authors apologize for the error. The updated figure and figure legend can be found below.

Figure 7.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 7.

HFS-induced long-term depression rescued in YAC128 by increasing 2-AG levels. A, Time course summary of normalized EPSC amplitude after HFS at time 0 in 1 month-old WT and YAC128(53) in indirect pathway SPNs (iSPNs). The same group of untreated YAC128(53) iSPN are shown in subsequent panels for comparison with drug treatment. B, Time course summary of untreated YAC128(53) iSPNs and YAC128(53) iSPNs treated with the FAAH inhibitor URB597 showing no difference in response to HFS. C, Summary and representative traces showing no difference in YAC128 iSPNs treated with URB597 (1 μm) compared with untreated YAC128 iSPNs. D, Time course summary of untreated YAC128 iSPNs and YAC128 iSPNs treated with the MAGL inhibitor JZL184 (10 μm) showing normalized EPSC amplitude after HFS. E, Mean responses (showing data at 35 min after LTD induction relative to baseline in each experiment from the time course summary in A for WT and untreated YAC128, and from D for YAC128 treated with JZL184) illustrate significantly greater reduction in WT compared with YAC128 iSPNs and in YAC128 iSPNs treated with JZL184 compared with untreated YAC128 iSPNs. Representative traces shown in inset: pre- and post-HFS in WT, YAC128, and YAC128 treated with JZL184. Scale: 100 pA, 20 ms. F, Paired-pulse ratio (PPR) of EPSC after HFS is increased in WT iSPNs and YAC128 treated with JZL184, but not untreated YAC 128 iSPNs.

Back to top

In this issue

The Journal of Neuroscience: 38 (33)
Journal of Neuroscience
Vol. 38, Issue 33
15 Aug 2018
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Advertising (PDF)
  • Ed Board (PDF)
Email

Thank you for sharing this Journal of Neuroscience article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Correction: Sepers et al., “Endocannabinoid-Specific Impairment in Synaptic Plasticity in Striatum of Huntington's Disease Mouse Model”
(Your Name) has forwarded a page to you from Journal of Neuroscience
(Your Name) thought you would be interested in this article in Journal of Neuroscience.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
View Full Page PDF
Citation Tools
Correction: Sepers et al., “Endocannabinoid-Specific Impairment in Synaptic Plasticity in Striatum of Huntington's Disease Mouse Model”
Journal of Neuroscience 15 August 2018, 38 (33) 7364; DOI: 10.1523/JNEUROSCI.1804-18.2018

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Request Permissions
Share
Correction: Sepers et al., “Endocannabinoid-Specific Impairment in Synaptic Plasticity in Striatum of Huntington's Disease Mouse Model”
Journal of Neuroscience 15 August 2018, 38 (33) 7364; DOI: 10.1523/JNEUROSCI.1804-18.2018
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Responses to this article

Respond to this article

Jump to comment:

No eLetters have been published for this article.

Related Articles

Cited By...

More in this TOC Section

  • Correction: Sequerra, Goyal et al., “NMDA Receptor Signaling Is Important for Neural Tube Formation and for Preventing Antiepileptic Drug-Induced Neural Tube Defects”
  • Correction: Darbelli et al., “Quaking Regulates Neurofascin 155 Expression for Myelin and Axoglial Junction Maintenance”
  • Correction: Personius et al., “Neuromuscular NMDA Receptors Modulate Developmental Synapse Elimination”
Show more Correction
  • Home
  • Alerts
  • Follow SFN on BlueSky
  • Visit Society for Neuroscience on Facebook
  • Follow Society for Neuroscience on Twitter
  • Follow Society for Neuroscience on LinkedIn
  • Visit Society for Neuroscience on Youtube
  • Follow our RSS feeds

Content

  • Early Release
  • Current Issue
  • Issue Archive
  • Collections

Information

  • For Authors
  • For Advertisers
  • For the Media
  • For Subscribers

About

  • About the Journal
  • Editorial Board
  • Privacy Notice
  • Contact
  • Accessibility
(JNeurosci logo)
(SfN logo)

Copyright © 2025 by the Society for Neuroscience.
JNeurosci Online ISSN: 1529-2401

The ideas and opinions expressed in JNeurosci do not necessarily reflect those of SfN or the JNeurosci Editorial Board. Publication of an advertisement or other product mention in JNeurosci should not be construed as an endorsement of the manufacturer’s claims. SfN does not assume any responsibility for any injury and/or damage to persons or property arising from or related to any use of any material contained in JNeurosci.